Literature DB >> 28031371

Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.

Chunfeng Li1, Zining Wang1,2, Yang Cao3, Lulan Wang1,4, Jingyun Ji5, Zhigao Chen1, Tao Deng6, Taijiao Jiang1, Genhong Cheng7,4, F Xiao-Feng Qin7.   

Abstract

Influenza virus RNA-dependent RNA polymerase consists of three viral protein subunits: PA, PB1, and PB2. Protein-protein interactions (PPIs) of these subunits play pivotal roles in assembling the functional polymerase complex, which is essential for the replication and transcription of influenza virus RNA. Here we developed a highly specific and robust bimolecular luminescence complementation (BiLC) reporter system to facilitate the investigation of influenza virus polymerase complex formation. Furthermore, by combining computational modeling and the BiLC reporter assay, we identified several novel small-molecule compounds that selectively inhibited PB1-PB2 interaction. Function of one such lead compound was confirmed by its activity in suppressing influenza virus replication. In addition, our studies also revealed that PA plays a critical role in enhancing interactions between PB1 and PB2, which could be important in targeting sites for anti-influenza intervention. Collectively, these findings not only aid the development of novel inhibitors targeting the formation of influenza virus polymerase complex but also present a new tool to investigate the exquisite mechanism of PPIs. IMPORTANCE Formation of the functional influenza virus polymerase involves complex protein-protein interactions (PPIs) of PA, PB1, and PB2 subunits. In this work, we developed a novel BiLC assay system which is sensitive and specific to quantify both strong and weak PPIs between influenza virus polymerase subunits. More importantly, by combining in silico modeling and our BiLC assay, we identified a small molecule that can suppress influenza virus replication by disrupting the polymerase assembly. Thus, we developed an innovative method to investigate PPIs of multisubunit complexes effectively and to identify new molecules inhibiting influenza virus polymerase assembly.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  BiLC; influenza inhibitor screening; influenza virus polymerase; protein-protein interactions

Mesh:

Substances:

Year:  2017        PMID: 28031371      PMCID: PMC5309938          DOI: 10.1128/JVI.02282-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Protein-protein interactions as targets for antiviral chemotherapy.

Authors:  Arianna Loregian; Howard S Marsden; Giorgio Palù
Journal:  Rev Med Virol       Date:  2002 Jul-Aug       Impact factor: 6.989

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.

Authors:  M Jaber Hossain; Sandra Perez; Zhu Guo; Li-Mei Chen; Ruben O Donis
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

Review 4.  Epidemiology, Evolution, and Recent Outbreaks of Avian Influenza Virus in China.

Authors:  Shuo Su; Yuhai Bi; Gary Wong; Gregory C Gray; George F Gao; Shoujun Li
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Structural insight into cap-snatching and RNA synthesis by influenza polymerase.

Authors:  Stefan Reich; Delphine Guilligay; Alexander Pflug; Hélène Malet; Imre Berger; Thibaut Crépin; Darren Hart; Thomas Lunardi; Max Nanao; Rob W H Ruigrok; Stephen Cusack
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

Review 6.  Drugs in development for influenza.

Authors:  David A Boltz; Jerry R Aldridge; Robert G Webster; Elena A Govorkova
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

7.  Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.

Authors:  Shitao Li; Lingyan Wang; Michael Berman; Young-Yun Kong; Martin E Dorf
Journal:  Immunity       Date:  2011-09-08       Impact factor: 31.745

Review 8.  Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes.

Authors:  Stéphane Y Corbel; Fabio M V Rossi
Journal:  Curr Opin Biotechnol       Date:  2002-10       Impact factor: 9.740

Review 9.  Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation.

Authors:  Tom K Kerppola
Journal:  Chem Soc Rev       Date:  2009-09-04       Impact factor: 54.564

10.  Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase.

Authors:  Kanako Sugiyama; Eiji Obayashi; Atsushi Kawaguchi; Yukari Suzuki; Jeremy R H Tame; Kyosuke Nagata; Sam-Yong Park
Journal:  EMBO J       Date:  2009-05-21       Impact factor: 11.598

View more
  4 in total

1.  Discovery of Influenza Polymerase PA-PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay.

Authors:  Jiantao Zhang; Yanmei Hu; Nan Wu; Jun Wang
Journal:  ACS Chem Biol       Date:  2019-11-21       Impact factor: 5.100

2.  Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.

Authors:  Chunfeng Li; Shulong Zu; Yong-Qiang Deng; Dapei Li; Kislay Parvatiyar; Natalie Quanquin; Jingzhe Shang; Nina Sun; Jiaqi Su; Zhenyang Liu; Min Wang; Saba R Aliyari; Xiao-Feng Li; Aiping Wu; Feng Ma; Yi Shi; Karin Nielsevn-Saines; Jae U Jung; Frank Xiao-Feng Qin; Cheng-Feng Qin; Genhong Cheng
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

3.  Ribonuclease from Bacillus Acts as an Antiviral Agent against Negative- and Positive-Sense Single Stranded Human Respiratory RNA Viruses.

Authors:  Raihan Shah Mahmud; Christin Müller; Yulia Romanova; Ahmed Mostafa; Vera Ulyanova; Stephan Pleschka; Olga Ilinskaya
Journal:  Biomed Res Int       Date:  2017-05-04       Impact factor: 3.411

4.  TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation.

Authors:  Shulong Zu; Chunfeng Li; Lili Li; Yong-Qiang Deng; Xiang Chen; Dan Luo; Qing Ye; Yi-Jiao Huang; Xiao-Feng Li; Rong-Rong Zhang; Nina Sun; Xianqi Zhang; Saba R Aliyari; Karin Nielsen-Saines; Jae U Jung; Heng Yang; Cheng-Feng Qin; Genhong Cheng
Journal:  Cell Biosci       Date:  2022-08-30       Impact factor: 9.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.